Smoking and mental health - NCSCT
Smoking and mental health - NCSCT
Smoking and mental health - NCSCT
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Summary <strong>and</strong> conclusions 10<br />
although at the time of writing (February 2013) proposals to test<br />
implementation in a set of early adopter prisons, planned for spring 2013,<br />
had been postponed.<br />
<strong>Smoking</strong> during <strong>and</strong> after pregnancy has major adverse effects on fetal <strong>and</strong><br />
child <strong>health</strong>. Women with <strong>mental</strong> disorders are more likely to smoke throughout<br />
pregnancy, <strong>and</strong> require systematic <strong>and</strong> sustained intervention <strong>and</strong> support to<br />
maximise smoking cessation. Many children in care have <strong>mental</strong> disorders, <strong>and</strong><br />
many smoke. It is important that child <strong>and</strong> adolescent <strong>mental</strong> <strong>health</strong> services,<br />
<strong>and</strong> local authority foster care <strong>and</strong> smoking policies, explicitly protect children<br />
from passive smoke, <strong>and</strong> provide smoke-free environments. Professionals<br />
working with or caring for young people should provide positive (ie nonsmoking)<br />
role models <strong>and</strong> hence be supported to quit smoking; they should also<br />
be trained to deliver cessation advice <strong>and</strong> provide or arrange further support for<br />
children who want help to quit.<br />
10.7 Economic costs of smoking in people with <strong>mental</strong> disorders<br />
<strong>Smoking</strong> in people with <strong>mental</strong> disorders causes an estimated 2.6 million<br />
hospital admissions, 3.1 million GP consultations <strong>and</strong> 18.8 million prescriptions<br />
each year, at a cost of around £720m per annum. Most of this cost arises from<br />
smoking in people with anxiety or depression. Psychotropic drug costs are<br />
increased by smoking, through more rapid drug metabolism, potentially by as<br />
much as £40m per year. Preventing smoking in people with <strong>mental</strong> disorders<br />
would avoid all of these costs, <strong>and</strong> gain up to 1 million discounted <strong>and</strong> 4 million<br />
undiscounted life-years. <strong>Smoking</strong> cessation interventions <strong>and</strong> harm reduction<br />
strategies are both highly cost-effective in this population.<br />
10.8 Ethics<br />
People with <strong>mental</strong> disorders have an entitlement to smoking cessation support<br />
that is at least as strong as for those of the general population, but their need for<br />
support is in many cases greater. Prevention <strong>and</strong> treatment of smoking have<br />
failed this group for many years, <strong>and</strong> thus exacerbated the <strong>health</strong> inequalities<br />
sustained. It is therefore vital that patients with <strong>mental</strong> disorders receive at least<br />
the same level of access to smoking cessation treatment, <strong>and</strong> help with temporary<br />
abstinence, as members of the general population. Smoke-free policies, which<br />
help to break the culture of smoking in <strong>mental</strong> <strong>health</strong> settings, are a crucial<br />
component of this.<br />
The objectives of smoking cessation <strong>and</strong> tobacco control policies in the <strong>mental</strong><br />
<strong>health</strong>care context need to take into account the complexity of the care needs of<br />
people with <strong>mental</strong> <strong>health</strong> problems. The case law relating to smoking policies in<br />
formal <strong>mental</strong> <strong>health</strong>care settings <strong>and</strong> prisons suggests that a careful balance<br />
© Royal College of Physicians 2013 193